Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP204279.RAUWN-2qVPQtNymTbUA34abMdEo5OdDZKiVuMz3bFSjfE130_assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP204279.RAUWN-2qVPQtNymTbUA34abMdEo5OdDZKiVuMz3bFSjfE130_provenance.
• NP827569.RASq-V5U0ob4RUCHhF1cpybldoV7Ps5YusBpg0UgWdxm0130_assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827569.RASq-V5U0ob4RUCHhF1cpybldoV7Ps5YusBpg0UgWdxm0130_provenance.
• NP207980.RAVOAjguZlYEtrMpR8TL1fQw44XbyFu_HzzRRTyr8hVCQ130_assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP207980.RAVOAjguZlYEtrMpR8TL1fQw44XbyFu_HzzRRTyr8hVCQ130_provenance.
• NP920964.RAYB0P4nMz63zOk_doXSwL6tsGHM3AB1yW_dZGAC7S07Q130_assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP920964.RAYB0P4nMz63zOk_doXSwL6tsGHM3AB1yW_dZGAC7S07Q130_provenance.
• NP321682.RA_HXI17pFCx34whlmRu4DCxogkkQlfhe5pa8xMh3Xpz8130_assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321682.RA_HXI17pFCx34whlmRu4DCxogkkQlfhe5pa8xMh3Xpz8130_provenance.
• NP451270.RAdAzmglYGVXgY4J65pwpCRyIWm7qSCU2EyTCF-_YFQcM130_assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP451270.RAdAzmglYGVXgY4J65pwpCRyIWm7qSCU2EyTCF-_YFQcM130_provenance.
• NP458891.RAeIh2gfjzwwYo7bYYIrhx8CW-fJfeZHHB_f4RDBg3LkA130_assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458891.RAeIh2gfjzwwYo7bYYIrhx8CW-fJfeZHHB_f4RDBg3LkA130_provenance.
• NP659358.RATBZjnKkTgNT5mJA1kFFfLeBiI00c6e8MSG_ONY-k2qg130_assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP659358.RATBZjnKkTgNT5mJA1kFFfLeBiI00c6e8MSG_ONY-k2qg130_provenance.
• NP662391.RATgnbLX0YQ-xdVrsxgV7eU8oa_K6Bqb3sYT5Q3odkM9c130_assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP662391.RATgnbLX0YQ-xdVrsxgV7eU8oa_K6Bqb3sYT5Q3odkM9c130_provenance.
• assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP702105.RACdcJ1vyMJw30kPKZbnybgygit6BxXTKuRYwzSZHCM_Y130_assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP702105.RACdcJ1vyMJw30kPKZbnybgygit6BxXTKuRYwzSZHCM_Y130_provenance.
• NP702100.RATbjy-nx4Ug-PlgSJbiaYZIRfX5RbGPzgrQ2nKQMjW1U130_assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP702100.RATbjy-nx4Ug-PlgSJbiaYZIRfX5RbGPzgrQ2nKQMjW1U130_provenance.
• NP712038.RAma1l9w3aZ7f-PIeQ0uhfKl0bxTMXKfAIkJgqMUbTkR8130_assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712038.RAma1l9w3aZ7f-PIeQ0uhfKl0bxTMXKfAIkJgqMUbTkR8130_provenance.
• NP659371.RAMS88cDOjKpmpTxnxxRF2NbKJcl8_46_o-IW_8gwscys130_assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP659371.RAMS88cDOjKpmpTxnxxRF2NbKJcl8_46_o-IW_8gwscys130_provenance.
• NP712057.RAIWzaMX_aZait8WAdHE4Uee_9ghcvDPr8hjnKqBL2FXg130_assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712057.RAIWzaMX_aZait8WAdHE4Uee_9ghcvDPr8hjnKqBL2FXg130_provenance.
• NP662399.RA3YBKfg7j02LYujki2TVOJibHF48NEmbIViki8KHvsZE130_assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP662399.RA3YBKfg7j02LYujki2TVOJibHF48NEmbIViki8KHvsZE130_provenance.
• NP702098.RAJPNOXf-J1-TIiz2eu5qiXoG1jDxLjLR9jrjr6rk7M6M130_assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP702098.RAJPNOXf-J1-TIiz2eu5qiXoG1jDxLjLR9jrjr6rk7M6M130_provenance.
• NP702096.RAw-KZ3Fh3ejyS0B_bFwxd3RkcXMq2LmkxA3T5YZJ6KOA130_assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP702096.RAw-KZ3Fh3ejyS0B_bFwxd3RkcXMq2LmkxA3T5YZJ6KOA130_provenance.
• NP702097.RA1P0Od-RIDiI9GuZO220c7hgGRSLxOVb3Mcw5igyusU4130_assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP702097.RA1P0Od-RIDiI9GuZO220c7hgGRSLxOVb3Mcw5igyusU4130_provenance.
• NP702103.RA2wl4gQ7JfNlJBcZFFVhgKI7J8bX_YLONAFK0cthy8_I130_assertion description "[To test the hypothesis that FYN, a member of the SRC family of kinases (SFKs), is up-regulated in prostate cancer, as FYN is functionally distinct from other SFKs, and interacts with FAK and paxillin (PXN), regulators of cell morphology and motility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP702103.RA2wl4gQ7JfNlJBcZFFVhgKI7J8bX_YLONAFK0cthy8_I130_provenance.